Student or educator? Sign up with your school email and get 6 months of Pro free.
PreprintCited by 0

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

In silico design of bioactive chimeric peptide from archaeal antimicrobial peptides

Banerjee, Souvik, Chakraborty, Soham, Majumder, Kaustav · 2021

Abstract

Novel peptide therapeutics have been the cardinal part of modern-day research. Such therapies are being incorporated to prevent the adverse effects of globally emerging multi-drug resistant bacteria and various chronic human diseases which pose a great risk to the present world. In this study, we have designed a novel peptide therapy involving archaeal antimicrobial peptides. In silico predictions assign the peptide construct to be antigenic, non-allergenic, non-toxic and having stable physicochemical properties. The secondary and tertiary structures of the construct were predicted. The tertiary structure was refined for improving the quality of the predicted model. Computational tools predicted intracellular receptors in Escherichia coli , Klebsiella pneumoniae and the human body to be possible binding targets of the construct. In silico docking of modelled peptide with predicted targets, showed prominent results against targets for complex human diseases and that of bacterial infections. The stability of those docked complexes was confirmed with computational studies of conformational dynamics. Certainly, the designed peptide could be a potent therapeutic against multi-drug resistant bacteria as well as several human diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.08.14.456327

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 76

  1. 2002, Biosensing of arteriosclerotic nanoplaque formation and interaction with an HMG-CoA reductase inhibitor, Acta Physiol Scand, 176, 131, 10.1046/j.1365-201X.2002.01020.x · DOI
  2. 2021, BACE1 and cholinesterase inhibitory activities of compounds from Cajanus cajan and Citrus reticulata: an in silico study, In Silico Pharmacol, 9, 1
  3. 10.1002/prot.21495 · DOI · Paper page
  4. 10.1038/onc.2014.155 · DOI · Paper page
  5. 2018, Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control, Expert Rev Anti Infect Ther, 16, 749, 10.1080/14787210.2018.1522249 · DOI · Paper page
  6. 2019, A comprehensive review on MAPK: a promising therapeutic target in cancer, Cancers, 11, 1618, 10.3390/cancers11101618 · DOI · Paper page
  7. 10.4155/tde.13.104 · DOI · Paper page
  8. Buchan DWA , Jones DT (2019) The PSIPRED Protein Analysis Workbench: 20 years on. Nucleic Acids Res. https://doi.org/10.1093/nar/gkz297 · DOI · Paper page
  9. 2019, Short cationic peptide derived from Archaea with dual antibacterial properties and anti-infective potential, ACS Infect Dis, 5, 1081, 10.1021/acsinfecdis.9b00073 · DOI
  10. 2017, (–)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury, Brain Res, 1677, 118, 10.1016/j.brainres.2017.09.015 · DOI
  11. 2017, Lactobionic acid enhances the synergistic effect of nisin and thymol against Listeria monocytogenes Scott A in tryptic soy broth and milk, Int J Food Microbiol, 260, 36, 10.1016/j.ijfoodmicro.2017.08.013 · DOI
  12. 2009, Development of cell death-based method for the selectivity screening of caspase-1 inhibitors, Cytotechnol, 60, 77, 10.1007/s10616-009-9217-9 · doi:10.1007/s10616-009-9217-9
  13. 2019, SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules, Nucleic Acids Res, 47, 357, 10.1093/nar/gkz382 · DOI · Paper page
  14. 2014, AllerTOP v.2—a server for in silico prediction of allergens, J Mol Model, 20, 1
  15. 10.1186/1471-2105-8-1 · DOI · Paper page
  16. 10.1016/j.vaccine.2006.09.032 · DOI · Paper page
  17. 2008, Bioinformatic approach for identifying parasite and fungal candidate subunit vaccines, Open Vaccine J, 1, 22, 10.2174/1875035400801010022 · doi:10.2174/1875035400801010022
  18. Duhovny D , Nussinov R , Wolfson HJ (2002) Efficient Unbound Docking of Rigid Molecules. In: Gusfield et al. , (ed) Proceedings of the 2’nd Workshop on Algorithms in Bioinformatics (WABI) Rome, Italy, Lecture Notes in Computer Science 2452, Springer Verlag, pp. 185–200, · DOI · Paper page
  19. 10.1186/s13046-021-01871-4 · DOI · Paper page
  20. 10.1038/s41598-016-0001-8 · DOI · Paper page
  21. 2021, Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors, J Chromatogr B, 1162, 122469, 10.1016/j.jchromb.2020.122469 · doi:10.1016/j.jchromb.2020.122469
  22. Gasteiger E , Hoogland C , Gattiker A , Duvaud S , Wilkins MR , Appel RD , Bairoch A (2005) Protein Identification and Analysis Tools on the ExPASy Server. In: John M. Walker (ed) The Proteomics Protocols Handbook, Humana Press, pp 571–607 · DOI · Paper page
  23. 2012, ChEMBL: a large-scale bioactivity database for drug discovery, Nucleic Acids Res, 40, 1100, 10.1093/nar/gkr777 · DOI · Paper page
  24. 10.1016/j.clbc.2011.03.021 · DOI · Paper page
  25. 10.1371/journal.pone.0073957 · DOI · Paper page
  26. 2019, Combatting antibiotic-resistant bacteria using nanomaterials, Chem Soc Rev, 48, 415, 10.1039/C7CS00748E · DOI · Paper page
  27. 2020, Peptide-drug conjugates and their targets in advanced cancer therapies, Front Chem, 8, 571, 10.3389/fchem.2020.00571 · DOI · Paper page
  28. 10.1038/s41598-018-23276-8 · DOI · Paper page
  29. 2013, GalaxyRefine: Protein structure refinement driven by side-chain repacking, Nucleic Acids Res, 41, 384, 10.1093/nar/gkt458 · DOI · Paper page
  30. 10.1006/jmbi.1999.3091 · DOI · Paper page
  31. 10.1097/00004872-198402040-00008 · doi:10.1097/00004872-198402040-00008
  32. 2016, Hydroxyurea: clinical and hematological effects in patients with sickle cell anemia, Glob J Health Sci, 8, 252
  33. 2021, Squamous cell carcinoma during long term hydroxyurea treatment: A case report, Int J Surg Case Rep, 85, 106160, 10.1016/j.ijscr.2021.106160 · doi:10.1016/j.ijscr.2021.106160
  34. 10.1093/nar/gkn750 · DOI · Paper page
  35. 2021, PubChem in 2021: new data content and improved web interfaces, Nucleic acids Res, 49, 1388, 10.1093/nar/gkaa971 · DOI · Paper page
  36. 10.1042/bj1550117 · DOI
  37. 10.1016/j.jmb.2007.05.022 · DOI · Paper page
  38. 10.1021/ci200227u · DOI · Paper page
  39. 10.3390/pathogens2020288 · DOI · Paper page
  40. 10.1002/jor.23656 · DOI · Paper page
  41. 2013, Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer, Mol Cancer Therap, 12, 2200, 10.1158/1535-7163.MCT-13-0095 · DOI
  42. 10.1016/j.bbcan.2019.05.009 · DOI
  43. 2020, Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma, Cancer Lett, 491, 146, 10.1016/j.canlet.2020.07.032 · DOI
  44. 2019, NETO2 promotes pancreatic cancer cell proliferation, invasion and migration via activation of the STAT3 signaling pathway, Cancer Management Res, 11, 5147, 10.2147/CMAR.S204260 · doi:10.2147/cmar.s204260
  45. 2014, iMODS: internal coordinates normal mode analysis server, Nucleic Acids Res, 42, 271, 10.1093/nar/gku339 · DOI · Paper page
  46. 2010, The potential for caspases in drug discovery, Curr Opin Drug Discov Dev, 13, 568
  47. 2016, Antimicrobial peptides: an emerging category of therapeutic agents, Front Cell Infect Microbiol, 6, 194
  48. 2017, Bacterial intelligence: imitation games, time-sharing, and long-range quantum coherence, J Cell Commun Signal, 11, 281, 10.1007/s12079-017-0394-6 · DOI
  49. 2019, Antimicrobial peptides, polymorphic toxins, and self-nonself recognition systems in archaea: an untapped armory for intermicrobial conflicts, MBio, 10, e00715
  50. 10.1093/nar/gkn186 · DOI · Paper page
  51. 2017, Bacteriocin-antimicrobial synergy: a medical and food perspective, Front Microbiol, 8, 1205, 10.3389/fmicb.2017.01205 · DOI · Paper page
  52. 2021, Cathepsin D—Managing the Delicate Balance, Pharmaceutics, 13, 837, 10.3390/pharmaceutics13060837 · DOI
  53. 2021, Trends in peptide drug discovery, Nat Rev Drug Discov, 20, 309, 10.1038/s41573-020-00135-8 · DOI · Paper page
  54. 10.1007/s10637-013-9929-8 · DOI
  55. 2020, Activity of Biodegradable Polymeric Nanosponges against Dual-Species Bacterial Biofilms, ACS Biomater Sci Eng, 7, 1780
  56. 2021, DBAASP v3: Database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics, Nucleic Acids Res, 49, 288, 10.1093/nar/gkaa991 · DOI · Paper page
  57. 10.1107/S0907444902008132 · doi:10.1107/s0907444902008132
  58. 10.1186/1471-2164-15-349 · DOI · Paper page
  59. 2019, Potential role of biofilm formation in the development of digestive tract cancer with special reference to Helicobacter pylori infection, Front Microbiol, 10, 846, 10.3389/fmicb.2019.00846 · DOI
  60. 10.1093/nar/gki481 · DOI · Paper page
  61. 10.1002/prot.340170404 · DOI · Paper page
  62. 2016, The cell killing mechanisms of hydroxyurea, Genes, 7, 99, 10.3390/genes7110099 · DOI · Paper page
  63. 10.2165/00003495-198800363-00016 · DOI
  64. 10.1074/jbc.271.42.25898 · DOI
  65. 10.1021/ar900036b · DOI · Paper page
  66. 2021, The role of peptide-based therapeutics in oncotherapy, J Drug Target, 6, 1
  67. 10.1038/nature.2017.21550 · DOI · Paper page
  68. 2020, Synthesis, In Silico and In Vitro Evaluation of Some Flavone Derivatives for Acetylcholinesterase and BACE-1 Inhibitory Activity, Molecules, 25, 4064, 10.3390/molecules25184064 · DOI
  69. 10.3389/fphar.2014.00275 · DOI
  70. 10.1158/1535-7163.MCT-08-0126 · DOI · Paper page
  71. 2020, Collection of antimicrobial peptides database and its derivatives: Applications and beyond, Protein Sci, 29, 36, 10.1002/pro.3714 · DOI
  72. 2011, Aliskiren: An orally active renin inhibitor, J Pharm Bioallied Sci, 3, 189, 10.4103/0975-7406.80764 · DOI
  73. 2007, ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins, Nucleic Acids Res, 35, 407, 10.1093/nar/gkm290 · DOI · Paper page
  74. 2015, Protein Structure and Function Prediction Using I-TASSER, Curr Protoc Bioinform, 52, 5
  75. 2006, Formal Synthesis of the ACE Inhibitor Benazepril· HCl via an Asymmetric Aza-Michael Reaction, Mol, 11, 641, 10.3390/11080641 · doi:10.3390/11080641
  76. 10.1615/CritRevImmunol.2019030225 · DOI

Metadata

Authors
Banerjee, S., Chakraborty, S., & Majumder, K.
Publisher
openRxiv
Published
2021-08-15
Cited by
0
References
1
Type
Preprint

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In silico design of bioactive chimeric peptide from archaeal antimicrobial peptides. https://app.cochat.ai/papers/10.1101/2021.08.14.456327
The paper
Banerjee, S., Chakraborty, S., & Majumder, K. (2021). In silico design of bioactive chimeric peptide from archaeal antimicrobial peptides. https://doi.org/10.1101/2021.08.14.456327

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.